Fosun’s app allows users in China to register for BioNTech COVID vaccines In Hong Kong

HONG KONG (Reuters) – China’s Fosun Pharmaceutical said users of its health mobile app in China can now register to have COVID-19 vaccinations in Hong Kong using BioNTech’s vaccine.

(Reporting by Meg Shen and Ryan Woo; Editing by Andrew Heavens)